These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 16099033
1. Mathematical modeling of material-induced blood plasma coagulation. Guo Z, Bussard KM, Chatterjee K, Miller R, Vogler EA, Siedlecki CA. Biomaterials; 2006 Feb; 27(5):796-806. PubMed ID: 16099033 [Abstract] [Full Text] [Related]
2. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI. Mitropoulos KA. Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760 [Abstract] [Full Text] [Related]
6. Contributions of contact activation pathways of coagulation factor XII in plasma. Chatterjee K, Guo Z, Vogler EA, Siedlecki CA. J Biomed Mater Res A; 2009 Jul; 90(1):27-34. PubMed ID: 18481791 [Abstract] [Full Text] [Related]
7. Competitive-protein adsorption in contact activation of blood factor XII. Zhuo R, Siedlecki CA, Vogler EA. Biomaterials; 2007 Oct; 28(30):4355-69. PubMed ID: 17644174 [Abstract] [Full Text] [Related]
8. Procoagulant stimulus processing by the intrinsic pathway of blood plasma coagulation. Zhuo R, Miller R, Bussard KM, Siedlecki CA, Vogler EA. Biomaterials; 2005 Jun; 26(16):2965-73. PubMed ID: 15603791 [Abstract] [Full Text] [Related]
9. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group. Golas A, Pitakjakpipop H, Rahn MS, Siedlecki CA, Vogler EA. Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791 [Abstract] [Full Text] [Related]
11. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation. Schousboe I. Biochem Pharmacol; 2008 Mar 01; 75(5):1007-13. PubMed ID: 17996217 [Abstract] [Full Text] [Related]
12. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII. Schousboe I, Nystrøm BT, Hansen GH. FEBS J; 2008 Oct 01; 275(20):5161-72. PubMed ID: 18793325 [Abstract] [Full Text] [Related]
13. Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer. Woodruff RS, Xu Y, Layzer J, Wu W, Ogletree ML, Sullenger BA. J Thromb Haemost; 2013 Jul 01; 11(7):1364-73. PubMed ID: 23692437 [Abstract] [Full Text] [Related]
14. Defective thrombus formation in mice lacking coagulation factor XII. Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B. J Exp Med; 2005 Jul 18; 202(2):271-81. PubMed ID: 16009717 [Abstract] [Full Text] [Related]
15. A nanobody-based method for tracking factor XII activation in plasma. de Maat S, van Dooremalen S, de Groot PG, Maas C. Thromb Haemost; 2013 Sep 18; 110(3):458-68. PubMed ID: 23349032 [Abstract] [Full Text] [Related]
16. Potential-mediated and time-controlled first order activation of factor XII (Hageman factor) adsorbed to carbon surfaces. Randriamahazaka HN, Nigretto JM. Blood Coagul Fibrinolysis; 1994 Aug 18; 5(4):567-73. PubMed ID: 7841313 [Abstract] [Full Text] [Related]
19. Autoactivation of blood factor XII at hydrophilic and hydrophobic surfaces. Zhuo R, Siedlecki CA, Vogler EA. Biomaterials; 2006 Aug 18; 27(24):4325-32. PubMed ID: 16644008 [Abstract] [Full Text] [Related]